Skip to main content

Table 1 Experimental groups used for gene expression profiling

From: Combining global genome and transcriptome approaches to identify the candidate genes of small-effect quantitative trait loci in collagen-induced arthritis

Group

Treatment

RNA source

No. of mice

CV (percentage)

DBA/1_NC

None

LN from naive control DBA/1

3

22.8

DBA/1_PI

CFA + collagen II

LN from DBA/1 at day 10 after immunisation

3

20.4

DBA/1_OA

CFA + collagen II

LN from DBA/1 mice at day 35 after immunisation

3

21.7

DBA/1_CA

CFA + collagen II

LN from DBA/1 mice at day 95 after immunisation

3

25.8

FVB/N_NC

None

LN from naive control FVB/N

3

21.1

FVB/N_PI

CFA + collagen II

LN from FVB/N at day 10 after immunisation

3

22.6

FVB/N_OA

CFA + collagen II

LN from FVB/N mice at day 35 after immunisation

3

18.4

FVB/N_CA

CFA + collagen II

LN from FVB/N mice at day 95 after immunisation

3

21.1

  1. CA, chronic arthritis; CFA; complete Freund's adjuvant; CV, coefficient of variation; LN, lymph node; NC, naive control; OA, onset of arthritis; PI, post-immunisation.